Here’s the Dr. Fauci Statement That Could Mean Good News for Inovio

1 min read

Inovio Pharmaceuticals (NASDAQ: INO) was among the first to start clinical trials on a coronavirus vaccine candidate. But the biotech company wasn’t among the first to cross the vaccine race finish line. The U.S. Food and Drug Administration (FDA) last fall placed one of Inovio’s vaccine trials on a partial clinical hold, and the program fell behind.

Now, Inovio’s candidate is in phase 2. The clinical-stage biotech company also is working on a next-generation vaccine. And a recent statement by White House chief medical advisor Dr. Anthony Fauci may mean good news for one of these programs.

Image source: Getty Images.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Forget Coinbase: These Are 3 of the Best Stocks You Can Buy Right Now

Next Story

Better Buy: Lululemon vs. Peloton

Latest from Blog